View More View Less
  • 1 Budapest Körvasút sor 75/B 1158
Restricted access

Az időskori maculadegeneratio (AMD) létrejöttében és későbbi alakulásában az endothel-diszfunkciónak (ED) kulcsszerepe van. Az endothelfunkció-zavarra, illetve annak következményes kóros működésbeli, strukturális és anyagcsere-elváltozásaira különböző gyógyszerek (ACE-inhibitorok, AR-blokkolók, statinok, acetilszalicilsav, trimetazidin) kedvező hatással vannak. Az ED kedvező befolyásolásának, sikeres kezelésének jótékony hatása, az idült vascularis, cardiovascularis betegségekben mára már evidencia: az ACE-gátlók, az AR-blokkolók és a statinok helyreállítják az oxidatív stressz (OS) indukálta ED-ban a felborult egyensúlyt a vasoconstrictorok és vasodilatatorok, a növekedési faktorok és azok gátlói, a proinflammatorok és antiinflammatorok, valamint a prothromboticus és fibrinolyticus tényezők között, gátolják az OS kifejlődését, illetve káros hatásainak kialakulását; a thrombocyta-antiaggregatiós pleiotrop aspirin az endothel nyugalmi állapotának helyreállításában működik hatásosan közre, a trimetazidin pedig segít normalizálni, helyreállítani az elégtelenül funkcionáló szervszövet kóros anyagcserestátuszát. Mivel a humán érrendszer egységes, konszubsztanciális, ezért az ED-ban kedvezően ható gyógyszerek a szem, illetve a retina ereiben is előnyösen hatnak. A fentiek alapján logikus a feltevés, hogy elsődleges és másodlagos prevenciós tevékenység részeként adjunk ilyen gyógyszereket 1) azoknak, akiknek ugyan nincsen maculopathiájuk, de fennállnak az ED-t indukáló AMD-rizikótényezők, és 50 évesek elmúltak; 2) azoknak a betegeknek – a másik szem maculadegeneratiós károsodásának kialakulását megelőzendő –, akiken egyoldali maculopathiát állapítottak meg; 3) végül azoknak – a rosszabbodás kivédése és az esetleges javulás reményében –, akiknél mindkét szemen maculadegeneratiót diagnosztizáltak. – Természetesen emellett törekedjünk az OS-t és konszekutív ED-t indukáló maculadegeneratiós rizikótényezők teljes kiiktatására. – Dolgozatomban a fenti, indirekt bizonyítékokon is alapuló következtetéseket tárgyalom meg.

  • Fischer T.: Über die medikamentöse Praevention und die praeventive Behandlung der altersbedingten Makuladegeneration (AMD) durch die günstige Beeinflussung der Gefäßendotheldysfunktion (ED). Klin. Monatsbl. Augenheilkd., 2004, 221 , 1062.

    Fischer T. , 'Über die medikamentöse Praevention und die praeventive Behandlung der altersbedingten Makuladegeneration (AMD) durch die günstige Beeinflussung der Gefäßendotheldysfunktion (ED) ' (2004 ) 221 Klin. Monatsbl. Augenheilkd. : 1062 -.

    • Search Google Scholar
  • Fischer T.: Paralipomena zur vorangegangenen Veröffentlichung (Klin. Monatsbl. Augenheilkd. 2004, 221, 1062). Klin. Monatsbl. Augenheilkd., 2006, 223 , 178–179.

    Fischer T. , 'Paralipomena zur vorangegangenen Veröffentlichung ' (2006 ) 223 Klin. Monatsbl. Augenheilkd. : 178 -179.

    • Search Google Scholar
  • Fischer T.: Az időskori macula-degeneratio gyógyszeres megelőzése és preventív kezelése az endotheldiszfunkció kedvező befolyásolásával. Orv. Hetil., 2006, 147 , 2465–2468.

    Fischer T. , 'Az időskori macula-degeneratio gyógyszeres megelőzése és preventív kezelése az endotheldiszfunkció kedvező befolyásolásával ' (2006 ) 147 Orv. Hetil. : 2465 -2468.

    • Search Google Scholar
  • Kékes E.: Az endothel diszfunkció kezelése. Gyógyszereink, 2002, 52 , 153–162.

    Kékes E. , 'Az endothel diszfunkció kezelése ' (2002 ) 52 Gyógyszereink : 153 -162.

  • Fischer T.: Referensi megjegyzés a humán érrendszer részeinek egylényegűségéről. Orv. Hetil., 2006, 147 , 1145.

    Fischer T. , 'Referensi megjegyzés a humán érrendszer részeinek egylényegűségéről ' (2006 ) 147 Orv. Hetil. : 1145 -.

    • Search Google Scholar
  • Ferrari, R., Guardigli, G.: Angiotensin II overproduction: enemy of the vascular wall. Eur. Heart J., 2004, 4 (Suppl. A) , A26–A30.

    Guardigli G. , 'Angiotensin II overproduction: enemy of the vascular wall ' (2004 ) 4 Eur. Heart J. : A26 -A30.

    • Search Google Scholar
  • Heagerty, A. M.: Effect of ATI-receptor blockade on vascular structure and function. Eur. Heart J., 2004, 6 (Suppl. H) , H17–H21.

    Heagerty A. M. , 'Effect of ATI-receptor blockade on vascular structure and function ' (2004 ) 6 Eur. Heart J. : H17 -H21.

    • Search Google Scholar
  • Jackson, E. K.: Renin and angiotensin: drugs affecting renal and cardiovascular function. In Goodman and Gilman’s Pharmacologic Basis of Therapeutics. Szerk.: Brunton, L. L., Lazo, J. S., Parker, K. L., McGraw-Hill, N. Y., 2005, 789–808.

    Jackson E. K. , '', in Goodman and Gilman’s Pharmacologic Basis of Therapeutics , (2005 ) -.

  • Kwang Kon Koh, Yeong Yeal Abn, Seung Hwan Han és mtsai: Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J. Am. Coll. Cardiol., 2003, 42 , 905–910.

    Seung H. H. , 'Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients ' (2003 ) 42 J. Am. Coll. Cardiol. : 905 -910.

    • Search Google Scholar
  • Lonn, E., Gerstein, H. C., Smieja, M. és mtsai: Mechanism of cardiovascular risk reduction of ACE inhibitor ramipril: insights from HOPE and HOPE substudies. Eur. Heart J., 2003, 5 (Suppl. A) , A43–A48.

    Smieja M. , 'Mechanism of cardiovascular risk reduction of ACE inhibitor ramipril: insights from HOPE and HOPE substudies ' (2003 ) 5 Eur. Heart J. : A43 -A48.

    • Search Google Scholar
  • Soehnlein, O., Schmeisser, A., Cicho, J. és mtsai: ACE inhibition lowers angiotensin-II-induces monocyte ahesion to HUVEC by reduction of p65 translocation and ATI expression. J. Vasc. Res., 2005, 42 , 399–407.

    Cicho J. , 'ACE inhibition lowers angiotensin-II-induces monocyte ahesion to HUVEC by reduction of p65 translocation and ATI expression ' (2005 ) 42 J. Vasc. Res. : 399 -407.

    • Search Google Scholar
  • Task Force of ACE-Is of European Society of Cardiology: Expert consensus document on angiotensin converting enzyme inhibitor in vascular disease. Eur. Heart J., 2004, 25 , 1454–1470.

    'Expert consensus document on angiotensin converting enzyme inhibitor in vascular disease ' (2004 ) 25 Eur. Heart J. : 1454 -1470.

    • Search Google Scholar
  • Wassman, S., Nickenig, G.: The role of AT 1 -receptor in the cardiovascular continuum. Eur. Heart J., 2004, 6 (Suppl. H) , H3–H9.

    Nickenig G. , 'The role of AT1-receptor in the cardiovascular continuum ' (2004 ) 6 Eur. Heart J. : H3 -H9.

    • Search Google Scholar
  • Wassman, S., Laufs, N., Bauner, A. T. és mtsai: Inhibition of geranygeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells. Mol. Pharmacol., 2001, 59 , 649–654.

    Bauner A. T. , 'Inhibition of geranygeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells ' (2001 ) 59 Mol. Pharmacol. : 649 -654.

    • Search Google Scholar
  • Ceriello, A.: New insights on oxidative stress and diabetic complication may lead to a „causal” antioxidant therapy. Diabetes Care, 2003, 25 , 1589–1596.

    Ceriello A. , 'New insights on oxidative stress and diabetic complication may lead to a „causal” antioxidant therapy ' (2003 ) 25 Diabetes Care : 1589 -1596.

    • Search Google Scholar
  • Landmesser, M. és Harrison, D. G.: Oxidant stress as a marker for cardiovascular events. Ox marks the spot. Circulation, 2001, 104 , 2638–2640.

    Harrison D. G. , 'Oxidant stress as a marker for cardiovascular events. Ox marks the spot ' (2001 ) 104 Circulation : 2638 -2640.

    • Search Google Scholar
  • Molavi, B., Metha, H. L.: Oxidative stress in cardiovascular disease: molecular basis of its deleterious effect, its detection, and therapeutic consideration. Curr. Opin. Cardiol., 2004, 19 , 477–493.

    Metha H. L. , 'Oxidative stress in cardiovascular disease: molecular basis of its deleterious effect, its detection, and therapeutic consideration ' (2004 ) 19 Curr. Opin. Cardiol. : 477 -493.

    • Search Google Scholar
  • Asselberg, F. W., van der Harst, P., Jessurum, G. A. J. és mtsai: Clinical impact of vasomotor assessment and role of ACE-inhibitors and AR-blockers. Vasc. Pharmacol., 2005, 42 , 125–140.

    Jessurum G. A. J. , 'Clinical impact of vasomotor assessment and role of ACE-inhibitors and AR-blockers ' (2005 ) 42 Vasc. Pharmacol. : 125 -140.

    • Search Google Scholar
  • McKelvie, R. S., Yusuf, S., Pericak, D. és mtsai: Comparison of candesartan, enalapril, and their combination in congestive heart failure. Circulation, 1999, 100 , 1056–1064.

    Pericak D. , 'Comparison of candesartan, enalapril, and their combination in congestive heart failure ' (1999 ) 100 Circulation : 1056 -1064.

    • Search Google Scholar
  • McMurray, J., Solomon, S., Piepera, K. és mtsai: The effect of valsartan, captopril or both on arteriosclerotic events after acute myocardial infarction. J. Am. Coll. Cardiol., 2006, 47 , 726–733.

    Piepera K. , 'The effect of valsartan, captopril or both on arteriosclerotic events after acute myocardial infarction ' (2006 ) 47 J. Am. Coll. Cardiol. : 726 -733.

    • Search Google Scholar
  • Almutti, K., Rimawi, R., Spevack, D. és mtsa: Effects of Statins beyond lipid lowering: Potential for clinical benefits. Internat. J. Cardiol., 2006, 109 , 7–15.

    Spevack D. , 'Effects of Statins beyond lipid lowering: Potential for clinical benefits ' (2006 ) 109 Internat. J. Cardiol. : 7 -15.

    • Search Google Scholar
  • Hall, N. F., Gale, C. R., Sudall, H. és mtsai: Risk of macular degeneration in users of statins: cross sectional study. BMJ, 2001, 323 , 375–376.

    Sudall H. , 'Risk of macular degeneration in users of statins: cross sectional study ' (2001 ) 323 BMJ : 375 -376.

    • Search Google Scholar
  • Liao, J. K., Laufs, U.: Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol., 2005, 45 , 89–118.

    Laufs U. , 'Pleiotropic effects of statins ' (2005 ) 45 Annu. Rev. Pharmacol. Toxicol. : 89 -118.

    • Search Google Scholar
  • Minoru, M., Atachi, Y., Yamada, H. és mtsai: Chorioidal neovascularisation is provided by bone marrow cells. Stem. Cells, 2004, 22 , 2126.

    Yamada H. , 'Chorioidal neovascularisation is provided by bone marrow cells ' (2004 ) 22 Stem. Cells : 2126 -.

    • Search Google Scholar
  • Niessen, S. E., Tuzcu, E. M., Crowe, T. és mtsai: Statin-therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N. Eng. J. Med., 2005, 352 , 28–38.

    Crowe T. , 'Statin-therapy, LDL cholesterol, C-reactive protein, and coronary artery disease ' (2005 ) 352 N. Eng. J. Med. : 28 -38.

    • Search Google Scholar
  • Ray, K., Cannon, C. D.: The potential relevance of the multiple lipid indpendent (pleiotropic) effects of the statins. J. Am. Coll. Cardiol., 2005, 46 , 1425–1433.

    Cannon C. D. , 'The potential relevance of the multiple lipid indpendent (pleiotropic) effects of the statins ' (2005 ) 46 J. Am. Coll. Cardiol. : 1425 -1433.

    • Search Google Scholar
  • Wydlanski, M. E., Gokce, N., Keanea, J. E. és mtsai: The clinical implication of endothelial dysfunction. J. Am. Coll. Cardiol., 2003, 42 , 1149–1160.

    Keanea J. E. , 'The clinical implication of endothelial dysfunction ' (2003 ) 42 J. Am. Coll. Cardiol. : 1149 -1160.

    • Search Google Scholar
  • Honjo, M., Tanihara, H., Nishijima, K. és mtsai: Statins inhibit leukocyte-endothelial interaction and prevent neuronal death induced by ischemia-reperfusion injury in the rat retina. Arch. Ophthalmol., 2002, 120 , 1707–1713.

    Nishijima K. , 'Statins inhibit leukocyte-endothelial interaction and prevent neuronal death induced by ischemia-reperfusion injury in the rat retina ' (2002 ) 120 Arch. Ophthalmol. : 1707 -1713.

    • Search Google Scholar
  • Palinsky, W., Tsimiskas, S.: Immunomodulatory effects of statins. J. Am. Soc. Nephrol., 2002, 13 , 1673–1681.

    Tsimiskas S. , 'Immunomodulatory effects of statins ' (2002 ) 13 J. Am. Soc. Nephrol. : 1673 -1681.

    • Search Google Scholar
  • McGwin, G., Owsley, C., Curcio, C. A. és mtsai: The association between statin use and age related maculopathy. Br. J. Ophthalmol., 2003, 87 , 1121–1125.

    Curcio C. A. , 'The association between statin use and age related maculopathy ' (2003 ) 87 Br. J. Ophthalmol. : 1121 -1125.

    • Search Google Scholar
  • Wu, R., Lamontagne, D., Champlain, J. és mtsai: Anti-oxidative properties of acetylsalicylic acid on vascular tissues from rats. Circulation, 2002, 105 , 387–392.

    Champlain J. , 'Anti-oxidative properties of acetylsalicylic acid on vascular tissues from rats ' (2002 ) 105 Circulation : 387 -392.

    • Search Google Scholar
  • Wu, R., Laplante, M., Champlain, J. és mtsai: Prevention of angiotensin-II-induced oxidative stress, hypertension and cardiovascular hypertrophy by acetylsalicylic acid. J. Hypertens., 2004, 22 , 797–801.

    Champlain J. , 'Prevention of angiotensin-II-induced oxidative stress, hypertension and cardiovascular hypertrophy by acetylsalicylic acid ' (2004 ) 22 J. Hypertens. : 797 -801.

    • Search Google Scholar
  • Coyas, A.: The efficacy of trimetazidine in cochleovostibular disorders of ischemic origin. A crossover control versus placebo trial. Annales d’Oto-Larygologe et de Chirurge Cervico-Faciale, 1990, 1 (107 Suppl) , 81–87.

    Coyas A. , 'The efficacy of trimetazidine in cochleovostibular disorders of ischemic origin. A crossover control versus placebo trial ' (1990 ) 1 Annales d’Oto-Larygologe et de Chirurge Cervico-Faciale : 81 -87.

    • Search Google Scholar
  • Fragasso, G., Palloshi, A., Puccetti, P. és mtsai: A randomized trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J. Am. Coll. Cardiol., 2006, 48 , 992–998.

    Puccetti P. , 'A randomized trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure ' (2006 ) 48 J. Am. Coll. Cardiol. : 992 -998.

    • Search Google Scholar
  • Vitalem, C., Wajngaten, M., Sposato, B. és mtsai: Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur. Heart J., 2004, 25 , 1814–1821.

    Sposato B. , 'Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease ' (2004 ) 25 Eur. Heart J. : 1814 -1821.

    • Search Google Scholar
  • Országos Gyógyszerészeti Intézet: Gyógyszer Kompendium. MediMedia Információs Kft., Budapest, 2002, 75.

    '', in Gyógyszer Kompendium , (2002 ) -.

  • Seddom, J. M., Rifai, N.: Association with C-reactive protein and age-related macular degeneration. JAMA, 2004, 281 , 704–710.

    Rifai N. , 'Association with C-reactive protein and age-related macular degeneration ' (2004 ) 281 JAMA : 704 -710.

    • Search Google Scholar
  • Seddom, J. M., George, S., Rosner, B. és mtsai: Progression of age-related macular degeneration: Prospective assesment of C-reactive protein interleukin-6, and other cardiovascular biomarkers. Arch. Ophthalmol., 2005, 123 , 774–783.

    Rosner B. , 'Progression of age-related macular degeneration: Prospective assesment of C-reactive protein interleukin-6, and other cardiovascular biomarkers ' (2005 ) 123 Arch. Ophthalmol. : 774 -783.

    • Search Google Scholar
  • Desoriet, D. D., Klavier, C. C., Witteman, J. C. és mtsai: Complement factor I. polymorphism, complement activators and risk of age-related macular degeneration. JAMA, 2006, 286 , 301–309.

    Witteman J. C. , 'Complement factor I. polymorphism, complement activators and risk of age-related macular degeneration ' (2006 ) 286 JAMA : 301 -309.

    • Search Google Scholar
  • Fichtlscherer, S., Breuer, S., Schaehinger, V. és mtsai: C-reactive protein levels determine systemic nitric oxide bioavailability. Eur. Heart J., 2004, 25 , 1412–1415.

    Schaehinger V. , 'C-reactive protein levels determine systemic nitric oxide bioavailability ' (2004 ) 25 Eur. Heart J. : 1412 -1415.

    • Search Google Scholar
  • Kern, M. J.: Conditions associated with impaired endothelial function, and surrogate soluble markers of endothelial dysfunction. In Brauwald’s Heart Disease. Szerk.: Zipes, D. P., Libby, P., Bonow, R. O., and Brauwald, E., Elsevier-Saunders, Philadelphia, 2005, 1108–1109.

    Kern M. J. , '', in Brauwald’s Heart Disease , (2005 ) -.

  • Verma, S., Szmitko, P. E., Ridker, P. M.: C-reactive protein comes of age. Nat. Clin. Pract. Cardiovasc. Med., 2005, 2 , 29–36.

    Ridker P. M. , 'C-reactive protein comes of age ' (2005 ) 2 Nat. Clin. Pract. Cardiovasc. Med. : 29 -36.

    • Search Google Scholar
  • Lip, G. Y. H., Blann, A., Hope-Ross, M. és mtsai: Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorrheology and endothelial dysfunction. Ophthalmology, 2001, 108 , 705–710.

    Hope-Ross M. , 'Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorrheology and endothelial dysfunction ' (2001 ) 108 Ophthalmology : 705 -710.

    • Search Google Scholar
  • Becker, B. F., Heindl, B., Kupatt, C. és mtsai: Endothelial function and hemostasis. Zeitschrift Kardiol., 2000, 89 , 160–70.

    Kupatt C. , 'Endothelial function and hemostasis ' (2000 ) 89 Zeitschrift Kardiol. : 160 -70.

  • Lip, G. Y. H., Blann, A.: von Willebrand factor: a marker of endothelial dysfunction in vascular disorder? Cardiovasc. Res., 1997, 34 , 255–265.

    Blann A. , 'von Willebrand factor: a marker of endothelial dysfunction in vascular disorder? ' (1997 ) 34 Cardiovasc. Res. : 255 -265.

    • Search Google Scholar
  • Ridker, P. M., Cannon, C. P., Morrow, D. és mtsai: C-reactive protein and outcomes after statin therapy. N. Eng. J. Med., 2005, 352 , 20–28.

    Morrow D. , 'C-reactive protein and outcomes after statin therapy ' (2005 ) 352 N. Eng. J. Med. : 20 -28.

    • Search Google Scholar
  • Beatty, S., Henson, D., Boulton, M. és mtsai: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Survey Ophthalmol., 2000, 45 , 115–134.

    Boulton M. , 'The role of oxidative stress in the pathogenesis of age-related macular degeneration ' (2000 ) 45 Survey Ophthalmol. : 115 -134.

    • Search Google Scholar
  • Judge, S., Leeuvenburgh, C.: Cardiac mitochondrial bioenergetics, oxidative stress, and aging. Am. J. Physiol. Cell Physiol., 2007, 292 , C1983–1992.

    Leeuvenburgh C. , 'Cardiac mitochondrial bioenergetics, oxidative stress, and aging ' (2007 ) 292 Am. J. Physiol. Cell Physiol. : C1983 -1992.

    • Search Google Scholar
  • Nádasdy A.: Szakmai interjú az AMD-ről Berta A. professzorral.; Orvosok Lapja, 2006. március, 57–58.

  • Penfold, P. L., Matigan, M. C., Gillies, M. C. és mtsai: Immunological and aetiological aspects of macular degeneration. Progr. Retinal Eye Res., 2001, 20 , 385–415.

    Gillies M. C. , 'Immunological and aetiological aspects of macular degeneration ' (2001 ) 20 Progr. Retinal Eye Res. : 385 -415.

    • Search Google Scholar
  • Salacz Gy.: A látást befolyásoló degeneratív betegségek. Orv. Hetil., 1999, 140 , 1507–1511.

    Salacz Gy. , 'A látást befolyásoló degeneratív betegségek ' (1999 ) 140 Orv. Hetil. : 1507 -1511.

    • Search Google Scholar
  • Seddom, J. M., Rosner, B., George, S. és mtsai: Progression of age-related macular degeneration. Association with body mass index, wirst circumference, and waist-hip ratio. Arch. Ophthalmol., 2003, 121 , 785–792.

    George S. , 'Progression of age-related macular degeneration. Association with body mass index, wirst circumference, and waist-hip ratio ' (2003 ) 121 Arch. Ophthalmol. : 785 -792.

    • Search Google Scholar
  • Tomany, S. C., Leenwen, R., Klein, R. és mtsai: Risk factors for incident age-related macular degeneration. Ophthalmology, 2004, 111 , 1280–1287.

    Klein R. , 'Risk factors for incident age-related macular degeneration ' (2004 ) 111 Ophthalmology : 1280 -1287.

    • Search Google Scholar
  • Vingerling, J. R., Dielemans, I., Bots, M. L. és mtsai: Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am. J. Epidemiol., 1995, 142 , 404–409.

    Bots M. L. , 'Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study ' (1995 ) 142 Am. J. Epidemiol. : 404 -409.

    • Search Google Scholar
  • Beckman, K. B., Ames, B. M.: The free radical theories of aging. Physiol. Rev., 1998, 78 , 547–581.

    Ames B. M. , 'The free radical theories of aging ' (1998 ) 78 Physiol. Rev. : 547 -581.

  • Dröge, W.: Free radicals in the physiological control of cell function. Progr. Cardiovasc. Dis., 1995, 378 , 129–154.

    Dröge W. , 'Free radicals in the physiological control of cell function ' (1995 ) 378 Progr. Cardiovasc. Dis. : 129 -154.

    • Search Google Scholar
  • Greene, D. G., Stevens, M. J., Obrosova, I. és mtsai: Glucose-induced oxidative stress and programmed cell death in diabetes mellitus. Eur. J. Pharmacol., 1999, 375 , 217–223.

    Obrosova I. , 'Glucose-induced oxidative stress and programmed cell death in diabetes mellitus ' (1999 ) 375 Eur. J. Pharmacol. : 217 -223.

    • Search Google Scholar
  • Keaney, J. V. és Vita, J. A.: Oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog. Cardiovasc. Dis., 1995, 378 , 129–154.

    Vita J. A. , 'Oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action ' (1995 ) 378 Prog. Cardiovasc. Dis. : 129 -154.

    • Search Google Scholar
  • Valgimigli, M., Merli, N., Malgutt, D. és mtsai: Endothelial dysfunction: Evidence for pathogenetic role of oxidative stress. Arch. Biochem. Biophysics, 2003, 420 , 255–261.

    Malgutt D. , 'Endothelial dysfunction: Evidence for pathogenetic role of oxidative stress ' (2003 ) 420 Arch. Biochem. Biophysics : 255 -261.

    • Search Google Scholar
  • Basso, N., Paglia, N., Stella, J. és mtsai: Protective effect of inhibition of the renin-angiotensin system on aging and oxidative stress. Regul. Pep., 2005, 128 , 247–252.

    Stella J. , 'Protective effect of inhibition of the renin-angiotensin system on aging and oxidative stress ' (2005 ) 128 Regul. Pep. : 247 -252.

    • Search Google Scholar
  • Hanig, B., Landmesser, U., Kahler, C. és mtsai: Comparative effect of ACE inhibitor and angiotensin II type I receptor antagonism on bioavailability of nitric oxide: role of superoxide dysmutase. Circulation, 2001, 103 , 799–805.

    Kahler C. , 'Comparative effect of ACE inhibitor and angiotensin II type I receptor antagonism on bioavailability of nitric oxide: role of superoxide dysmutase ' (2001 ) 103 Circulation : 799 -805.

    • Search Google Scholar
  • Augustin, A. J., Dick, J., Offermann, J. és mtsai: Bedeutung oxidativer Mechanismen bei Erkrankungen der Netzhaut. Klin. Monatsbl. Augenheilkd., 2002, 219 , 631–643.

    Offermann J. , 'Bedeutung oxidativer Mechanismen bei Erkrankungen der Netzhaut ' (2002 ) 219 Klin. Monatsbl. Augenheilkd. : 631 -643.

    • Search Google Scholar
  • AREDS Study Group: A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch. Ophthalmology, 2001, 119 , 1417–1436.

    'A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss ' (2001 ) 119 Arch. Ophthalmology : 1417 -1436.

    • Search Google Scholar
  • Cheitlin, M. D.: Erectile dysfunction: the earliest sign of generalized vascular disease? J. Am. Coll. Cardiol., 2004, 43 , 185–186.

    Cheitlin M. D. , 'Erectile dysfunction: the earliest sign of generalized vascular disease? ' (2004 ) 43 J. Am. Coll. Cardiol. : 185 -186.

    • Search Google Scholar
  • Kaiser, D. R., Billups, K., Mason, C. és mtsai: Impaired brachial artery endothelium dependent and independent vasodilatation in men with erectile dysfunction and no other clinical cardiovascular disease. J. Am. Coll. Cardiol., 2004, 43 , 179–184.

    Mason C. , 'Impaired brachial artery endothelium dependent and independent vasodilatation in men with erectile dysfunction and no other clinical cardiovascular disease ' (2004 ) 43 J. Am. Coll. Cardiol. : 179 -184.

    • Search Google Scholar
  • Targonski, P. V., Bonetti, P. O., Pumper, G. M. és mtsai: Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation, 2003, 107 , 2805–2809.

    Pumper G. M. , 'Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events ' (2003 ) 107 Circulation : 2805 -2809.

    • Search Google Scholar
  • Witt, N., Wong, T. Y., Hughes, A. D., Chaturvedi, N. és mtsai: Abnormalities in retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension, 2006, 47 , 975–981.

    Chaturvedi N. , 'Abnormalities in retinal microvascular structure and risk of mortality from ischemic heart disease and stroke ' (2006 ) 47 Hypertension : 975 -981.

    • Search Google Scholar
  • Voutilainen-Kaunisto, T., Uusitupa, M. I., Terasvirta, M. E. és mtsa: Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects. Diabetes Care, 2000, 23 , 1672–1678.

    Terasvirta M. E. , 'Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects ' (2000 ) 23 Diabetes Care : 1672 -1678.

    • Search Google Scholar
  • Snow, K., Seddom, J. M.: Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmol. Epidemiol., 1999, 6 , 125–143.

    Seddom J. M. , 'Do age-related macular degeneration and cardiovascular disease share common antecedents? ' (1999 ) 6 Ophthalmol. Epidemiol. : 125 -143.

    • Search Google Scholar
All Time Past Year Past 30 Days
Abstract Views 51 51 3
Full Text Views 15 4 0
PDF Downloads 4 2 0